Anbio Biotechnology (NASDAQ:NNNN) Shares Gap Up – Should You Buy?

Anbio Biotechnology (NASDAQ:NNNN)’s stock price gapped up before the market opened on Thursday . The stock had previously closed at $26.60, but opened at $31.00. Anbio Biotechnology shares last traded at $26.4570, with a volume of 165 shares traded.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings downgraded shares of Anbio Biotechnology from a “hold (c-)” rating to a “sell (d+)” rating in a report on Wednesday, April 1st. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, Anbio Biotechnology currently has an average rating of “Sell”.

Anbio Biotechnology Trading Down 0.2%

The company has a fifty day moving average price of $25.22.

Anbio Biotechnology (NASDAQ:NNNN) last released its quarterly earnings data on Tuesday, April 7th. The company reported $0.03 EPS for the quarter.

About Anbio Biotechnology

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.